These results demonstrated that cisplatin enhanced lysosomal biosynthesis by activating TFEB in HCC, causing synergistic mitochondrial‐lysosomal crosstalk and enhancing mitophagy. The gene discussed is TFEB; the disease is hepatocellular carcinoma.